Division Voting information
James Brokenshire voted No - against a party majority and against the House
One of 65 Conservative No votes vs 105 Conservative Aye votes
Tally: Ayes - 383 Noes - 73
James Brokenshire voted Aye - against a party majority and in line with the House
One of 112 Conservative Aye votes vs 188 Conservative No votes
Tally: Ayes - 412 Noes - 202
James Brokenshire voted No - against a party majority and against the House
One of 99 Conservative No votes vs 127 Conservative Aye votes
Tally: Ayes - 376 Noes - 107
James Brokenshire voted Aye - against a party majority and in line with the House
One of 124 Conservative Aye votes vs 134 Conservative No votes
Tally: Ayes - 366 Noes - 161
James Brokenshire voted No - against a party majority and in line with the House
One of 99 Conservative No votes vs 121 Conservative Aye votes
Tally: Ayes - 150 Noes - 340
James Brokenshire voted No - against a party majority and in line with the House
One of 92 Conservative No votes vs 126 Conservative Aye votes
Tally: Ayes - 163 Noes - 321
James Brokenshire voted Aye - against a party majority and in line with the House
One of 131 Conservative Aye votes vs 139 Conservative No votes
Tally: Ayes - 400 Noes - 175
James Brokenshire voted Aye - against a party majority and in line with the House
One of 2 Conservative Aye votes vs 82 Conservative No votes
Tally: Ayes - 206 Noes - 90
James Brokenshire voted Aye - against a party majority and in line with the House
One of 30 Conservative Aye votes vs 85 Conservative No votes
Tally: Ayes - 322 Noes - 157
James Brokenshire voted No - against a party majority and in line with the House
One of 60 Conservative No votes vs 79 Conservative Aye votes
Tally: Ayes - 163 Noes - 342
James Brokenshire voted Aye - against a party majority and in line with the House
One of 75 Conservative Aye votes vs 96 Conservative No votes
Tally: Ayes - 305 Noes - 267
James Brokenshire voted Aye - against a party majority and in line with the House
One of 55 Conservative Aye votes vs 121 Conservative No votes
Tally: Ayes - 337 Noes - 224
James Brokenshire voted Aye - against a party majority and against the House
One of 34 Conservative Aye votes vs 105 Conservative No votes
Tally: Ayes - 122 Noes - 354
James Brokenshire voted No - against a party majority and against the House
One of 55 Conservative No votes vs 69 Conservative Aye votes
Tally: Ayes - 365 Noes - 62
All Debates
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
Sparring Partners
View All Sparring PartnersDepartment Debates
(2124 debate contributions)
(745 debate contributions)
(376 debate contributions)
(71 debate contributions)
Legislation Debates
(18,342 words contributed)
(12,460 words contributed)
(5,880 words contributed)
(5,760 words contributed)
Latest EDMs signed by James Brokenshire
Commons initiatives
These initiatives were driven by James Brokenshire, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
James Brokenshire has not been granted any Urgent Questions
1 Adjournment Debate led by James Brokenshire
6 Bills introduced by James Brokenshire
A Bill to make provision enabling the Commissioners for Her Majesty’s Revenue and Customs to incur expenditure in connection with digital services to be provided by them for the purpose of facilitating the administration or payment of non-domestic rates in England
This Bill received Royal Assent on Thursday 4th July 2019 and was enacted into law.
Make provision prohibiting landlords and letting agents from requiring certain payments to be made or certain other steps to be taken; to make provision about the payment of holding deposits; to make provision about enforcement and about the lead enforcement authority; to amend the provisions of the Consumer Rights Act 2015 about information to be provided by letting agents; to make provision about client money protection schemes; and for connected purposes.
This Bill received Royal Assent on Tuesday 12th February 2019 and was enacted into law.
To make provision for buildings used as nursery grounds to be exempt from nondomestic rates in England and Wales.
This Bill received Royal Assent on Thursday 1st November 2018 and was enacted into law.
A Bill to extend the period of time for making Ministerial appointments following the election of the Northern Ireland Assembly on 2 March 2017, and to make provision about the regional rate in Northern Ireland for the year ending 31 March 2018.
This Bill received Royal Assent on Thursday 27th April 2017 and was enacted into law.
A Bill to authorise the issue out of the Consolidated Fund of Northern Ireland of certain sums for the service of the year ending 31 March 2018; to appropriate those sums for specified purposes; to authorise the Department of Finance in Northern Ireland to borrow on the credit of the appropriated sums; to authorise the use for the public service of certain resources(including accruing resources) for the year ending 31 March 2018; and to repeal certain spent provisions.
This Bill received Royal Assent on Thursday 16th November 2017 and was enacted into law.
Date TBA
James Brokenshire has not co-sponsored any Bills in the current parliamentary sitting
9 Written Questions
(View all written questions)Healthcare Quality Improvement Partnership (HQIP), as commissioner of the National Lung Cancer Audit (NLCA), has proposed a contract extension until after the publication date of the NLCA report on 11 June 2020. This extension has to be mutually agreed by the incumbent audit provider and HQIP are currently in discussions to confirm with them.
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
The current scheduled publication date for next National Lung Cancer Audit report is Thursday 11 June 2020.
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
No decisions on awarding the contract to prepare the next National Lung Cancer Audit have currently been made. The current contract is due to expire on 31 March 2020.
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
The National Clinical Audit and Patient Outcomes Programme (NCAPOP) is made up of a number of funding streams comprising over 30 topics and aim to mirror the priority areas set out in the NHS Long Term Plan. The National Quality Board (NQB) established an NQB NCAPOP Partners Group, with representation from NHS England and NHS Improvement, the Care Quality Commission, the National Institute for Health and Care Excellence (NICE) and Health Education England, amongst others, to ensure the NCAPOP portfolio continues to support the priorities of the wider National Health Service.
NCAPOP audits are commissioned by the Healthcare Quality Improvement Partnership (HQIP) which manages the programme on behalf of NHS England and NHS Improvement. In addition, NHS England and NHS Improvement have contractual accountability meetings to review the Key Performance indicators associated with the NCAPOP contract.
The following expenditure was provided for NCAPOP in recent years:
- 2016/17; £16.9 million;
- 2017/18; £16.9 million;
- 2018/19; £15.8 million; and
- 2019/20; £15.6 million.
Clinical audits delivered under the NCAPOP portfolio can be found at the following link:
https://www.hqip.org.uk/a-z-of-nca/#.XAlJvcK7KUk
NCAPOP outcome review of delivered work can be found at the following link:
https://www.hqip.org.uk/clinical-outcome-review-programmes/#.XiseTmC7JPY
Secretary of State for Digital, Culture, Media and Sport
The National Clinical Audit and Patient Outcomes Programme (NCAPOP) is made up of a number of funding streams comprising over 30 topics and aim to mirror the priority areas set out in the NHS Long Term Plan. The National Quality Board (NQB) established an NQB NCAPOP Partners Group, with representation from NHS England and NHS Improvement, the Care Quality Commission, the National Institute for Health and Care Excellence (NICE) and Health Education England, amongst others, to ensure the NCAPOP portfolio continues to support the priorities of the wider National Health Service.
NCAPOP audits are commissioned by the Healthcare Quality Improvement Partnership (HQIP) which manages the programme on behalf of NHS England and NHS Improvement. In addition, NHS England and NHS Improvement have contractual accountability meetings to review the Key Performance indicators associated with the NCAPOP contract.
The following expenditure was provided for NCAPOP in recent years:
- 2016/17; £16.9 million;
- 2017/18; £16.9 million;
- 2018/19; £15.8 million; and
- 2019/20; £15.6 million.
Clinical audits delivered under the NCAPOP portfolio can be found at the following link:
https://www.hqip.org.uk/a-z-of-nca/#.XAlJvcK7KUk
NCAPOP outcome review of delivered work can be found at the following link:
https://www.hqip.org.uk/clinical-outcome-review-programmes/#.XiseTmC7JPY
Secretary of State for Digital, Culture, Media and Sport
The National Clinical Audit and Patient Outcomes Programme (NCAPOP) is made up of a number of funding streams comprising over 30 topics and aim to mirror the priority areas set out in the NHS Long Term Plan. The National Quality Board (NQB) established an NQB NCAPOP Partners Group, with representation from NHS England and NHS Improvement, the Care Quality Commission, the National Institute for Health and Care Excellence (NICE) and Health Education England, amongst others, to ensure the NCAPOP portfolio continues to support the priorities of the wider National Health Service.
NCAPOP audits are commissioned by the Healthcare Quality Improvement Partnership (HQIP) which manages the programme on behalf of NHS England and NHS Improvement. In addition, NHS England and NHS Improvement have contractual accountability meetings to review the Key Performance indicators associated with the NCAPOP contract.
The following expenditure was provided for NCAPOP in recent years:
- 2016/17; £16.9 million;
- 2017/18; £16.9 million;
- 2018/19; £15.8 million; and
- 2019/20; £15.6 million.
Clinical audits delivered under the NCAPOP portfolio can be found at the following link:
https://www.hqip.org.uk/a-z-of-nca/#.XAlJvcK7KUk
NCAPOP outcome review of delivered work can be found at the following link:
https://www.hqip.org.uk/clinical-outcome-review-programmes/#.XiseTmC7JPY
Secretary of State for Digital, Culture, Media and Sport
The membership of the Clinical Expert Group (CEG) for Lung Cancer is listed below and publicly available on the Roy Castle Lung Cancer Foundation website. It will also be published on NHS England’s website shortly.
Lung Cancer Clinical Expert Group membership
Prof David Baldwin Respiratory Physician, East Midlands / Lung Cancer CEG Chair
Prof Sam Janes Chest Physician and Scientist, Early Detection, London / Lung Cancer CEG Vice Chair
Mrs Diana Borthwick Clinical Nurse Specialist in Lung Cancer / former Chair of National Lung Cancer Forum for Nurses
Dr Julie Hendry Respiratory Physician, Merseyside and Cheshire Cancer Network
Dr David Gilligan Clinical Oncologist, East of England
Dr Andrew Bates Clinical Oncologist, Southampton
Dr Anand Devaraj Thoracic Radiologist, London
Mrs Sue Maughn Commissioning Director-Cancer, East London Health and Care Partnership
Dr Amelia Randle General Practitioner The Park Surgery, Shepton Mallet / Clinical Lead Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance
Dr Paul Cane Consultant Histopathologist, London
Prof Denis Talbot Professor of Cancer Medicine, University of Oxford, Thames Valley Cancer Network
Dr Imran Husain Consultant Respiratory Physician, West Midlands
Dr Sanjay Popat Consultant Medical Oncologist, Royal Marsden Hospital
Dr Yvonne Summers Medical Oncologist, The Christie and University Hospital of South Manchester, Manchester
Dr Andrew Wilcock Clinical Reader in Palliative Medicine and Medical Oncology, Nottingham
Mr Martin Grange Patient Representative, Hampshire
Mrs Michele McMahon Patient Representative, Liverpool
Mrs Janette Rawlinson Patient Representative, West Midlands / European Lung Foundation Lung cancer patient advisory group / National Cancer Research Institute Clinical Studies Group (lung cancer) consumer member / British Thoracic Oncology Group steering committee member, Cancer Research UK SMP board member (patient representative) / Lay member Sandwell and West Birmingham Clinical Commissioning Group
Dr Robert Rintoul Reader in Thoracic Oncology, University of Cambridge / Honorary Consultant in Respiratory Medicine, Papworth Hospital, Cambridge
Dr Jeremy Killen Consultant in Respiratory Medicine, North of England
Dr Sion Barnard Thoracic Surgeon / Society of Cardiothoracic Surgeons
Mr Doug West Consultant Thoracic Surgeon, Bristol
Dr Neil Bayman Consultant Clinical Oncologist, Greater Manchester
Mrs Barbara Gill Programme Lead Accelerate, Coordinate, Evaluate (ACE), NHS England / Cancer Research UK
Dr Vytis Dudzevicius Consultant in Respiratory Medicine, London / Lung multidisciplinary team Lead and Lung Cancer Lead Clinician
Mrs Vanessa Beattie Clinical Nurse Specialist in Lung Cancer / National Lung Cancer Forum for Nurses Chair
Mrs Karen Clayton Macmillan Lung Cancer Lead Nurse, East Cheshire NHS Trust / National Lung Cancer Forum for Nurses
Dr Matthew Evison Consultant in Respiratory Medicine, Manchester / Director of the Lung Pathway Board for Greater Manchester Cancer
Dr Ian Woolhouse Respiratory Physician, Chair of West Midlands Lung Expert Advisory Group
The National Optimal Lung Cancer Pathway was developed with the assistance of further expert clinicians:
Dr Sadia Anwar Consultant Respiratory Physician, Nottingham
Dr Matthew Callister Consultant Respiratory Physician, Leeds
Dr Paul Beckett Consultant Respiratory Physician, Derby
Prof Mick Peake Consultant and Senior Lecturer in Respiratory Medicine / National Clinical Lead, NHS Cancer Improvement/ Clinical Lead, National Cancer Intelligence Network
The Clinical Expert Group for Lung Cancer published three documents in 2017/18, and also provided clinical advice for the development of a handbook to support delivery of best practice lung cancer pathways. Details of the documents and handbook are provided below.
- National Optimal Lung Cancer Pathway (2017);
- National Optimal Lung Cancer Pathway Implementation Guide (2017);
- Clinical Advice for the Provision of Lung Cancer Services (2017); and
- Handbook: Implementing a timed lung cancer diagnostic pathway (2018).